ATLANTA--(BUSINESS WIRE)--Inhibitex, Inc. (Nasdaq: INHX), today announced that Russell H. Plumb, President and Chief Executive Officer, is scheduled to present an overview of the company and its pipeline of differentiated antiviral compounds at the following two conferences:
